Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02980068 · ClinicalTrials.gov registry record · Phase 1
A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction
A Phase 1 study, sponsored by Gladwin, Mark, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 77
- Enrollment target
NCT02980068 is a Phase 1 study that has completed, run by Gladwin, Mark, MD. The registered enrollment target is 77 participants.
The verdict
NCT02980068, a Phase 1 study, has completed, sponsored by Gladwin, Mark, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 77 participants
- Enrollment target
Study Summary
This is an open-label, single-center study to examine distinguishing features of the structure and function of the oral and gut microbiome in healthy adult normal volunteers compared to volunteers with PH-HFpEF in the breakdown of oral nitrate.
Interventions
- DRUG 15N Nitrate
- DRUG 14N Nitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2022-02-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02980068
The ClinicalTrials.gov registry entry for NCT02980068 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gladwin, Mark, MD, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 15N Nitrate is the first listed.
NCT02980068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02980068 about?
NCT02980068 is a clinical study titled "A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction". This is an open-label, single-center study to examine distinguishing features of the structure and function of the oral and gut microbiome in healthy adult normal volunteers compared to volunteers with PH-HFpEF in the breakdown of oral nitrate.
What is the current status of trial NCT02980068?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 77 participants. The study started on 2017-08-28. Estimated completion is 2022-02-25.
What interventions are being tested in trial NCT02980068?
The interventions under investigation include: 15N Nitrate (DRUG), 14N Nitrate (DRUG).
Who is sponsoring clinical trial NCT02980068?
This trial is sponsored by Gladwin, Mark, MD, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.